ReviewFrontiers in molecular biosciences2026
Evolving computational paradigms for noncoding variant pathogenicity prediction.
Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of whole-genome sequencing (WGS) has highlighted the important contribution of noncoding variants to human disease, yet their pathogenic mechanisms remain difficult to resolve. Traditional statistical and experimental approaches often struggle to capture complex regulatory interactions or establish causal links, leaving many noncoding variants classified as variants of uncertain significance in clinical databases. Recent advances in computational modeling have substantially improved pathogenicity prediction by integrating genomic, epigenetic, and structural information. In parallel, genome language model (gLM)-inspired methods have enabled more context-aware interpretation of noncoding sequences and improved model generalization. This review summarizes current computational approaches, data modalities, and evaluation strategies for noncoding variant pathogenicity prediction, discusses key challenges in interpretability and data heterogeneity, and highlights emerging opportunities for clinical translation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.